Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …

A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and …

The FDA has informed Moderna that it needs more time to review the company’s COVID vaccine in children aged 12 …

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced the results of a real world study by …

Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early …

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …

Data from the Coronavirus Infection Survey (CIS), and pillars 1 and 2 of the NHS Test and Trace have measured …

MindMaze Healthcare, major leader in the multi billion-dollar digital neurotherapeutics market, has announced the first UK partnership for its MindPod™ …

A major US hospital-based clinical trial has highlighted the benefit of using nasal decolonisation to reduce ICU infections caused by …

French biotech company, Valneva, has announced positive results from the Phase III trial of its inactivated, adjuvanted COVID-19 vaccine candidate, …